Valuation: Haleon plc

Market Cap 31.7B 42.82B 37.1B 34.76B 59.6B 4,084B 60.52B 409B 160B 2,045B 161B 157B 6,819B P/E 2026 *
18.7x
P/E 2027 * 16.5x
Enterprise Value 38.57B 52.09B 45.13B 42.28B 72.51B 4,968B 73.62B 497B 194B 2,488B 196B 191B 8,295B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 3.21x
Free-Float
98.47%
Yield 2026 *
2.25%
Yield 2027 * 2.49%
1 day-0.44%
1 week-3.32%
Current month-1.38%
1 month-1.84%
3 months+8.64%
6 months-12.44%
Current year-4.40%
1 week 355.7
Extreme 355.7
372.1
1 month 354.1
Extreme 354.1
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%-3.32%-0.19%+6.18% 42.82B
+0.43%+4.31%+90.84%+130.99% 1,088B
+0.41%+1.27%+50.98%+50.05% 629B
-0.53%+1.04%+25.23%+63.46% 440B
-0.38%-0.11%+45.90%+37.55% 359B
-0.32%-0.94%+27.15%+36.38% 291B
-0.53%-1.70%+1.79%+4.81% 245B
+0.45%+2.05%+46.04%+58.54% 225B
-0.90%+1.35%-8.70%-51.95% 204B
+0.07%+3.12%+13.21%+69.84% 168B
Average -0.19%+0.98%+29.22%+40.58% 369.2B
Weighted average by Cap. +0.00%+1.89%+48.10%+65.46%

Financials

2026 *2027 *
Net sales 11.39B 15.39B 13.33B 12.49B 21.42B 1,468B 21.75B 147B 57.42B 735B 57.77B 56.52B 2,450B 11.87B 16.04B 13.89B 13.02B 22.32B 1,530B 22.67B 153B 59.85B 766B 60.21B 58.9B 2,554B
Net income 1.7B 2.29B 1.99B 1.86B 3.19B 219B 3.24B 21.88B 8.55B 109B 8.6B 8.42B 365B 1.92B 2.59B 2.25B 2.11B 3.61B 247B 3.67B 24.77B 9.68B 124B 9.74B 9.53B 413B
Net Debt 6.86B 9.27B 8.03B 7.53B 12.91B 884B 13.1B 88.52B 34.6B 443B 34.81B 34.05B 1,476B 6.42B 8.68B 7.52B 7.04B 12.08B 828B 12.26B 82.84B 32.38B 414B 32.58B 31.87B 1,382B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-08-13 GBX 358.50 -0.39% 1,314,976
26-08-12 GBX 359.90 -1.51% 13,624,912
26-08-11 GBX 365.40 +0.05% 13,876,145
26-08-10 GBX 365.20 -1.14% 10,044,621
26-08-07 GBX 369.40 -0.32% 19,877,858
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.599GBP
Average target price
4.208GBP
Spread / Average Target
+16.93%

Quarterly revenue - Rate of surprise